Nvidia GPUs tapped for Chan Zuckerberg project to use AI for disease research
Ian Tuttle
A new project of the Chan Zuckerberg Initiative that aims to use artificial intelligence to bolster medical research will rely on GPUs (graphics processing units) supplied by Nvidia (NASDAQ:NVDA).
The organization said its endeavor will "provide the scientific community with access to predictive models of healthy and diseased cells, which will lead to groundbreaking new discoveries that could help cure, prevent, or manage all diseases by the end of this century."
It will do so through the use of more than a thousand GPUs. The Verge identified the GPUs as Nvidia's (NVDA) H100.
GPUs support CPUs -- central processing units -- by handling repetitive functions and calculations concurrently, tasks essential in machine learning and AI.
The GPU cluster is expected to bolster openly available models of human cells that will allow researchers to collaboratively accelerate their work.
Initiative Co-Founder and Co-CEO Priscilla Chan noted that AI models could predict how an immune cell responds to an infection, what happens to cell if a child is born with a rare disease, or how an individual might respond to a new medication
These models will tap into datasets including those that are part of the Chan Zuckerberg CELL by GENE (CZ CELLxGENE) software tool, which contains large single-cell datasets of more than 50M cells.

More on Nvidia

The use of artificial intelligence in medical devices and drug development
Nvidia: Is The iPhone Moment Real?
Nvidia: Time To Get Out (Rating Downgrade)
Nvidia: Better To Enter Now Than Never
Nvidia, AMD GPUs see higher prices, lower volumes in August: UBS